Wnt Signaling Regulates Intermediate Precursor Production in the Postnatal Dentate Gyrus by Regulating Cxcr4 ExpressionChoe Y.a · Pleasure S.J.a-d
aDepartment of Neurology, Programs in bNeuroscience and cDevelopmental Stem Cell Biology, and dEli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California, San Francisco, Calif., USA Corresponding Author
Samuel J. Pleasure
675 Nelson Rising Lane
Room 214, UCSF
San Francisco, CA 94158 (USA)
Previous studies have examined the role of diverse signaling pathways in dentate neurogenesis, but how these signaling pathways are integrated remains unknown. Using mice that allow genetic manipulation of type 1 radial progenitors in the dentate, we show that forced induction of Wnt signaling leads to expansion of the intermediate progenitor cell (IPC) pool while selective activation of Sonic hedgehog (Shh) signaling drives neurogenesis without significant expansion of IPCs. Thus, both Wnt and Shh signaling are proneurogenic, but they act in distinct manners when their signaling is forced in subgranular zone radial progenitors. We examined potential targets of the Wnt pathway in these cells and found that Cxcr4 is a direct target of Lef1 in dentate gyrus progenitors and that loss of Cxcr4 in postnatal neurogenesis decreases the production of IPCs. This suggests that Wnt activation of dentate gyrus progenitors induces Cxcl12 signaling by regulating receptor expression. This study provides evidence that distinct morphogenic pathways have notably different roles in regulating ongoing dentate neurogenesis.
© 2012 S. Karger AG, Basel
Newborn neurons are produced in adult rodents in two distinct neurogenic niches - the subventricular zone and the subgranular zone (SGZ) in the dentate gyrus (DG). In the dentate, the adult neurogenic niche is formed by the interaction of multiple cell types including type 1 progenitors (radially oriented progenitors with glial markers), located at the border of the hilus and dentate granule cell layer. The position of type 1 progenitors in the SGZ allows them access to a range of neurogenic regulators, including Wnt  and Sonic hedgehog (Shh) , and both of these pathways are potent regulators of neurogenesis. Lineage tracing of Shh-responding cells previously showed that these are the postnatal quiescent neurogenic astrocytes which first appear in the dentate at late embryogenesis in the DG . Shh signaling mutants show a loss of neurogenic stem cells as well as diminished cell proliferation during early postnatal dentate development [4,5,6]. Also, mice with Wnt pathway mutations have long been known to have severe developmental dentate phenotypes [1,7,8,9], but manipulation of the Wnt pathway in adult rodents also leads to major defects in dentate neurogenesis , in part because of the role of Wnt in regulating key neurogenic factors like NeuroD in the neuroblast cells . How these pathways are integrated by type 1 stem cells in the SGZ and whether their effects are similar or redundant has not been addressed previously.
The most dramatic expansion of DG size as well as the number of DG granule neurons occurs during the first 2 weeks of postnatal life. During this time, there is extensive reorganization of the dentate stem cell niche [10,11,12]. However, by the end of this time, the dentate neurogenic niche is formed and the DG stem cells are localized specifically in the SGZ. Formation of the embryonic DG is regulated by Wnt from the cortical hem [7,11,13], and the Shh signaling pathway begins to be prominent at the late embryonic-perinatal period [3,6]. There is also abundant evidence that Shh and Wnt signaling continue to be important in later ongoing dentate neurogenesis (after P15) [1,2,3,5,14], but there is little understanding of how these pathways are integrated in their functions in the DG. We are particularly interested in the role of the Shh and Wnt signaling pathways in regulating the behavior of type 1 DG stem cells once the SGZ has been established and how the effects of these pathways differ and collaborate. Here, we examine how both Wnt and Shh signaling regulate the behavior of DG neural stem cells and show that Cxcr4 is an important downstream target of the Wnt pathway in the dentate neurogenic niche.
Gli1-CreERt2 , hGFAP-Cre , Cxcr4flx, Ctnnb1(Gof) and SmoM2  mouse lines were previously reported. Rosa-YFP mice were obtained from Jackson Laboratory (Bar Harbor, Me., USA). Experimental mice were generated by crossing Cre-expressing male mice with the homozygous conditional mutant female mice. All the lines were maintained in mixed genetic background. The day of vaginal plug was considered to be embryonic day 0.5 (E0.5) and the day of birth as postnatal day 1 (P1). Electroporation of green fluorescent protein (GFP) and CA-Cxcr4 (asparagine at 121 to alanine) was conducted using pregnant CD1 mice as described in the previous paper . Mouse colonies were housed at the University of California, San Francisco (UCSF), in accordance with the National Institutes of Health and the UCSF guidelines.
All experiments were done by comparing control and mutant sections stained on the same slides to reduce variation. Sections were prepared at 20-µm thickness and stored at -80°C until use. Slides were warmed to room temperature and treated with proteinase K (50 µg/ml) for 10 min and fixed with 4% paraformaldehyde for 10 min. Acetylation was performed using 0.25% acetic anhydride in 0.1 M triethanolamine, pH 8.0, for 10 min, followed by three 1× PBS washes. Slides were incubated with hybridization buffer [50% formamide, 5× SSC, 0.3 mg/ml yeast tRNA, 100 mg/ml heparin, 1× Denhardt's, 0.1% Tween 20, 0.1% CHAPS (3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate), 5 mM EDTA] for 10 min at 65°C, followed by overnight incubation with a digoxigenin (DIG)-labeled probe (500 ng/ml). Five high-stringency washes were performed with 0.2× SSC at 65°C. Slides were then incubated with alkaline phosphatase-conjugated anti-DIG and nitroblue tetrazolium/5-bromo-4-chloro-indolyl phosphate (Roche) for the detection of signals. Non-radioactive DIG-labeled probes were prepared using cDNA templates of Axin2 and Cxcr4 which were obtained from polymerase chain reaction (PCR) amplification using primers designed according to the sequence information from Allen Institute for Brain Science.
Tamoxifen (TM; Sigma) stock was prepared by dissolving the powder in corn oil (Sigma) at 20 mg/ml. P15 mice were injected with a single intraperitoneal dose of 2 mg/10 g per animal except for the conditional inhibition of a Cxcr4flx allele that was accomplished with daily injections from P15 to P17. Bromodeoxyuridine (BrdU; Roche) dissolved in PBS (10 mg/ml) was injected intraperitoneally at a dose of 100 mg/kg per animal for the labeling of S-phase cells.
Mouse brains were collected after intracardiac perfusion with 4% paraformaldehyde in 1× PBS followed by cryoprotection with 30% sucrose/PBS overnight. Optimal cutting temperature-embedded tissues were processed in a cryostat at 30-µm sections for immunostaining and at 20-µm sections for in situ hybridization. Primary antibodies used for immunostaining were chicken anti-GFP (1:1,000; Aves Labs), rabbit anti-GFP (1:1,000; Invitrogen), rabbit anti-Prox1 , rat anti-BrdU (1:200; Novus), mouse anti-NeuN (1:100; Millipore), rat anti-Ctip2 (1:500; Abcam), rabbit anti- BLBP (1:500, Chemicon; 1:300, Abcam), rabbit anti-Ki67 (1:200; LabVision), rabbit anti-Tbr2 (1:200; Abcam), and rabbit anti-LEF1 (1:100; Cell Signaling Technology). To normalize cell counting, we used medioseptal regions of the DG at +400 to +800 µm from the appearance of the DG (set as 0 µm) and presented the number of cells per single DG. We excluded temporal regions of the DG since the GFP+ cells were too crowded to count. We selected 3-6 sections from different mice to stain a single marker. We counted all GFP-positive cells in the area of confocal images that were acquired at the Nikon Imaging Center at the UCSF using an upright Nikon C1 spectral confocal microscope equipped with 405-, 488- and 561-nm lasers with 10×, 20× and 63× objective.
We used the ChIP-IT system (Active Motif) using rabbit and mouse anti-Lef1 antibody (Cell Signaling Technology and Abnova, respectively) for chromatin immunoprecipitation (IP) and used rabbit immunoglobulin G (IgG) as a negative control IP. Quantitative PCR was conducted using immunoprecipitates collected from three E17.5 embryonic DG tissues using the 7500 Fast Real-Time PCR system (Applied Biosystems). Primer pairs were Cxcr4p_F (cccaggaaactgcagtcatg) and Cxcr4p_R (cactccgttcgcagatgtac) for the promoter of mouse Cxcr4. Independent quantitative PCR was performed three times using a SYBR Green PCR master mix (Applied Biosystems), and the ΔΔCt value was used to present fold differences of relative binding activities using a value obtained from rabbit IgG without primary antibodies as a reference.
For the luciferase reporter assay, we used the dual luciferase system (Promega) using pGL3-luc (Promega) containing an SV40 minimal promoter as a vector backbone and a pRL-TK vector to normalize the transfection efficiencies. Using Lipofectamine 2000 (Invitrogen), we used a total of 2 µg plasmid DNA per single transfection in COS7 cells and collected cell extracts at 18 h after transfection. We cloned a 2.5-kb proximal region of the mouse Cxcr4 promoters into the pGL3-luc vector. Deletion of the promoter was conducted by PCR using primer combination of sense primers, Cxcr4p-s0 (GGGCTACTCAGCTATTACTAAC), Cxcr4p-s1 (GGGCTACATCATGAAAGGTAG) and Cxcr4p- s2m (gccaaatattatccttgaaag) and an antisense primer Cxcr4p-s2r (cacaggtctctttagctcctg) shown as a diagram in figure 4.
Values are presented as the mean ± SEM in plots. For statistical analyses, we used Student's t test and one-way ANOVA, and the p values of Tukey's post hoc test were presented after ANOVA (Graph Pad and Excel Software).
Our initial task was to validate a useful genetic tool for manipulating the DG stem cells selectively. One barrier has been the identification of adequate markers to identify the stem cells accurately. Previous studies have shown that they express Nestin, Sox2, BLBP and GFAP; however, each of these markers is also expressed by non-neurogenic astrocytes in the DG and elsewhere in the cortex. In order to identify a better marker, we examined the expression of Lef1 using an antibody suitable for immunohistochemisty. Lef1 is a required determinant of dentate granule cell specification , but expression has not been carefully examined in the dentate lineage. At P15 when the SGZ is established, Lef1 is expressed in cells sharing expression of the known radial progenitor marker BLBP, but not overlapping with either Tbr2 (an intermediate progenitor marker) or Prox1 (a postmitotic dentate granule cell marker; fig. 1a). Quantification of this staining showed that essentially all of the Lef1+ cells expressed BLBP, while virtually none expressed Tbr2 or Prox1 (fig. 1c). Thus, Lef1 appears to be a useful marker for DG stem cells and may indicate that this population of cells is poised to respond to Wnt ligands.
Next, we took advantage of the Gli1-CreERt2 mouse line that allows labeling of cells in the SGZ which are actively responding to Shh signaling  and crossed these with Rosa-YFP reporter mice. The benefit of the Gli1-CreERt2 line over Nestin-CreERt2 lines in our study is that we can label cells actively responding to Shh signaling at the time of TM injection. To take advantage of this line for examining the short-term labeling of Shh-responsive cells, we wanted to use only a single injection of TM at P15 followed by analysis of the labeled cells after 48 h. Gli1-CreERt2 recombined cells (after TM injection at P15, then examined 48 h later) are present in the SGZ. The labeled cells were costained with Blbp, GFAP and Sox2 which label SGZ radial glial (RG) stem cells, but not with Tbr2, for neurogenic transiently amplifying cells, PSA-NCAM and DCX for the immature neuroblast cells, and Prox1 for the mature DG granule neurons (data not shown). In addition, short-term analysis of the GFP-labeled cells combined with Lef1 staining showed that there is extensive overlap between the GFP+ and Lef1-expressing cells and that these cells included some portion of the actively dividing BrdU+ cells after a 1-hour BrdU pulse (fig. 1b). In addition, we found that essentially all the GFP+ cells expressed both BLBP and Lef1 at P17, 2 days after TM (fig. 1b-d). Thus, we conclude that Lef1 marks a population of SGZ progenitors which express RG stem cell markers that are actively Shh responsive, and the Gli1-CreERt2 line could prove useful for manipulating these cells.
To confirm that the GFP+ cells in the SGZ persist as long-lived DG stem cells, we observed Gli1-CreERt2 recombined cells at different time points. Several weeks after labeling, a few GFP+ cells were costained with Lef1 in the SGZ, and most of the GFP+ cells had migrated into the dentate granule cell layer, and by P120, there were numerous cells in the granule cell layer coexpressing GFP and Prox1 (data not shown). Thus, the Gli1-CreERt2 is an exceedingly useful tool, allowing recombination in a cohort of Shh-responding DG stem cells with a single injection of TM at P15 and marking these cells and their progeny long term. We also attempted to use the Gli1-CreERt2 mice to mark DG stem cells with TM injection at adult stages, but found that a single injection was inadequate to consistently drive recombination in a sufficient cohort of cells for clear analysis. Because multiple TM injections over several days were required in the adult mice, possibly because the adult dentate stem cells are more quiescent than the pubertal dentate stem cells, it precluded the type of shorter-term analysis we are interested in, and we confined our analysis to mice after P15 single injection.
Previous studies have demonstrated that both Wnt and Shh signaling are key regulators of postnatal dentate neurogenesis, but there has been little consideration of the different consequences of activation of these pathways. We reasoned that we could use the Gli1-CreERt2 mice to cell autonomously manipulate signaling in both of these pathways in a small cohort of homogeneous, actively Shh-responding RG stem cells. In this way, we would determine the lineage consequences of continued Shh signaling versus sustained Wnt signaling. To do this, we crossed Gli1-CreERt2 with the floxed exon 3 β-catenin allele [Ctnnb1(Gof), that leads to stabilization and tonic activation of β-catenin]  and with the floxed SmoM2 allele (that allows expression of a constitutively active Shh signaling receptor) . In each case, they will express dominantly active versions of these critical signaling proteins after Cre-mediated excision. We also crossed these mice with the Rosa-YFP reporter and used a single injection of TM at P15 to allow manipulation of a cohort of RG stem cells and then quantified the relative percentages of GFP+/BLBP+ RG stem cells, GFP+/Tbr2+ intermediate progenitors and GFP+/Prox1+ dentate granule cells in each condition after a 14-day survival period. Although the SmoM2 allele produces a SmoM2-GFP fusion protein that inserts into the cell membrane, it was undetectable, so we also made use of Rosa-YFP in these mice for the strong cytoplasmic GFP signal.
We found that both the SmoM2 and Ctnnb1(Gof) mice had a substantial increase in the number of total GFP+ cells compared to controls, indicating an increase in cell production from RG stem cells driven by either tonic Shh or Wnt signaling at P30 (fig. 2a). In both cases, this corresponds to a large increase in the production of total neurons and a significant increase in the percentages of RG stem cells in the dentate from among the GFP-labeled cells. However, there was a major divergence in the two experimental conditions with regard to the fraction of intermediate progenitor cells (IPCs) produced (fig. 2b, c). In the tonic Wnt activation mice, there was a dramatic increase in the fraction of IPCs, while in the SmoM2 mice, there was a decrease in this fraction, implying that Wnt activation and Shh activation may have distinct effects on the mode of neurogenesis.
To determine the longer-term consequences of our hedgehog and Wnt signaling manipulations on dentate neurogenesis, we wanted to allow mice to survive for longer times after single injection at P15. One complication we found was that survival was reduced in the Gli1-CreERt2;Ctnnb1(Gof) mice starting about 20 days after TM injection. This appeared to be due to a defect in subepithelial mesenchymal cells that have excess cell death leading to skin defects (data not shown). Thus, to allow Gli1-CreERt2;Ctnnb1(Gof) mice to survive, we had to decrease the dose of TM to half, making direct comparison of cell numbers between conditions impossible. However, we were able to compare the percentages at P60 (45 days after TM treatment) as we did at earlier survival times and found that again the activation of Wnt signaling leads to dramatic and significant increases in the percentage of IPCs in the cell cohort compared to Shh signaling activation or controls (fig. 2d, e). The total number of cells labeled with GFP and cell type-specific markers clearly demonstrate that the Tbr2 population is also increased by Wnt signaling at this age (fig. 2f).
However, tonic β-catenin activation does seem to -hinder the generation or survival of postmitotic Prox1-positive granule neurons compared to Shh signaling -activation. This leads to the somewhat paradoxical -finding that Ctnnb1(Gof) mice showed slightly decreased dentate granule cell layer areas (ANOVA, p < 0.05) -compared to the GFP or SmoM2 mice (online suppl. fig. 1; for all online supplementary material, see www.karger.com?doi=10.1159/000345353). This implies that neurons with tonic expression of Ctnnb1(Gof) may have difficulty integrating into the DG and are likely lost by cell death over time. We did not see any clear increase in cell death in the Ctnnb1(Gof) mice (data not shown), but we suspect this is due to the difficulty in choosing a specific time point for examination during the longer survival after TM treatment. Over this length of time, even a very small and imperceptible increase in cell death would be significant and lead to changes in overall neuronal survival but would be near impossible to document. However, we did see evidence that the neurons in Ctnnb1(Gof) mice do have immature dendritic trees, likely implying an inability to integrate into the dentate either as a primary or secondary effect of the Ctnnb1(Gof) expression (online suppl. fig. 2). This is probably due to direct roles of β-catenin in dendrite development that are not necessarily dependent on Wnt signaling [21,22]. To assess this, we measured the average number of dendritic branches labeled with GFP from 75 Prox1+ granule neurons and found significantly simplified neuronal dendritic morphologies in Ctnnb1(Gof) mice at P60 (online suppl. fig. 2). This indicates that the expression of stabilized β-catenin during maturation of granule neurons hinders dendritic elaboration and likely contributes to the difficulty for these new neurons to integrate into the dentate circuitry.
Our data suggest that activation of the β-catenin signaling pathway supports the production of cells with IPC markers in the dentate neurogenic lineage. To be sure that this phenotype was associated with expansion of the rapidly dividing pool of progenitors, we examined whether Wnt signaling activation increases the numbers of BrdU-labeled cells. We introduced TM at P15 and injected BrdU (30 mg/kg) four times at 6-hour intervals on P19 to saturate the proliferating cells. The number of BrdU/GFP double-positive cells was 2.5 times higher in the Gli1-CreERt2;Ctnnb1(gof) mutants, confirming that the IPC pool is expanded (fig. 3a, b). Gli1-CreERt2;SmoM2 mice also showed significant increase in cell proliferation; however, the clusters of GFP+;BrdU+ cells were more prominent in the Gli1-CreERt2;Ctnnb1 mice, probably indicative of intermediate progenitor expansion .
Thus, we suspect that transcriptional targets of the Wnt pathway in these cells are likely to be important in the production of IPCs. First, to demonstrate that tonic activation of the Wnt pathway leads to direct transcriptional activation of Wnt targets in the SGZ, we examined the expression of a well-described Wnt transcriptional target - Axin2 . We compared the expression of Axin2 in the SGZ in GFP controls to mice expressing SmoM2 or Ctnnb1(Gof) at 5 and 15 days after Gli1-CreERt2 activation with a single dose of TM. It is clear that in these mice, Axin2 expression is dramatically increased in the SGZ of mice expressing stabilized β-catenin compared to the other two conditions (fig. 3c, d). NeuroD transcription factors are known to promote neurogenesis by activation of Wnt signaling in the dentate neuroblasts ; however, we did not see the increased expression of NeuroD1 in the P40 Gli1-CreERt2;Ctnnb1(gof) mutant mice (data not shown). Thus, tonic activation of Wnt signaling in the type 1 DG stem cells seems to induce IPCs through other targets. We have previously noted that the distribution of Wnt transcriptional signaling in the developing medial cortex is quite similar to the expression of Cxcr4, a receptor for Cxcl12 and a known regulator of dentate development , so we wondered whether Cxcr4 expression was also upregulated in SGZ cells after activation of Wnt signaling. Agreeing with previous reports [25,26], Cxcr4 expression is prominent in the SGZ (fig. 3c, g) and is dramatically upregulated in mice that have had a recombination of the Ctnnb1(Gof) allele when compared to control or SmoM2 mice (fig. 3c, d). Along with the strong intensity of Cxcr4 expression in the Gli1-CreERt2;Ctnnb1(Gof) mice, the mice had increased numbers of expressing cells at P30 (fig. 3g). To determine whether Cxcr4 might be directly regulated by Wnt signaling, we examined the putative promoter region of the Cxcr4 gene and found three consensus Tcf/Lef-binding sites. Chromatin IP of complexes from brain extracts also showed that anti-Lef1 antibodies pull down fragments from the Cxcr4 promoter (fig. 3e). To more directly address the role of Lef1 in regulating Cxcr4 expression, we generated luciferase reporter constructs with the Cxcr4 promoter and compared their activity to control plasmids when cotransfected with Lef1. Indeed, Lef1 drives a moderate enhancement of Cxcr4 promoter activity, which is lost in deletion constructs lacking the three putative Lef1-binding sites (fig. 3f). Importantly, when we instead cotransfected a dominant active Lef1 construct with the DNA binding domain fused to the VP16 activation domain , we found much higher levels of induction of promoter activity that were again absent when the Lef1 binding sites were deleted (fig. 3f). Considering the specific expression of Lef1 in the RG cells and not in the IPCs, the induction of β-catenin expression should form heterodimeric activators with Lef1 in the RG cells and lead to downstream target activation and generation of IPCs from the RG cells. To determine whether ectopic signaling by Cxcr4 is able to induce IPC production from RG cells on its own, we electroporated a constitutively active form of Cxcr4 (CA-Cxcr4) into the embryonic ventricular zone and examined the production of IPCs compared to controls electroporated with GFP. We found that CA-Cxcr4 significantly expands the production of IPCs within the electroporated zone (fig. 3h, i). Interestingly a recent paper showed seemingly opposite results with stabilized β-catenin expression in the neocortex, where IPC production was decreased . We believe that this distinction is probably due to specific induction of IPCs by CA-Cxcr4 and that β-catenin expression alone did not activate Cxcr4 signaling in the RG cells. This likely indicates important distinctions between the developmental potential of neural stem cells in the medial cortical anlage (where the dentate forms) and the neocortex. It is quite likely in fact that the selective expression of Lef1 in the medial cortex is part of this distinction.
Previous studies from our lab showed that embryonic excision of Cxcr4 in the dentate leads to significant developmental defects and the loss of dividing progenitors from the embryonic and early postnatal dentate . In that previous study, we found that after excision with Emx1-Cre, the Cxcr4flx/flx mice show significant phenotypic rescue by P7, so that a phenotype was not visible at later postnatal stages . At that time, we wondered if this was molecular compensation by another pathway; however, because of our new data, we decided to revisit this issue. We generated hGFAP-Cre;Cxcr4flx/flx mice and found that with this Cre driver, which has continued expression in the dentate stem cell lineage from embryonic through postnatal stages, we now uncovered a dramatic postnatal dentate phenotype (fig. 4a, b). In these mice, the DG is smaller than normal and has dramatically reduced numbers of Tbr2+ and Ki67+ IPCs in the SGZ at postnatal stages (fig. 4a, b). One obvious issue with these results is that the prominent embryonic phenotype in Cxcr4 mutant mice is probably responsible for significant consequences on the postnatal structure and function of the SGZ . In the hGFAP-Cre;Cxcr4flx/flx mice, this is apparent when we examine markers of the SGZ and the overall dentate structure - it is clear that the RG scaffolding and overall numbers of dentate stem cells are severely disrupted in these mice (fig. 4a). Therefore, to assess the role of Cxcr4 in a comparable situation with our Wnt and Shh manipulations, we generated Gli1-CreERt2;Cxcr4flx/flx conditional mutant mice after a daily injection of TM at P15 to P17. Since we injected TM three times, we obtained more GFP+ cells than in single injected mice, which made it difficult to compare total GFP+ cells. Instead, we counted Tbr2+ IPCs that were also GFP+ in controls versus experimental littermates and found a significant decrease in the numbers of GFP+ IPCs in the mutants (fig. 4e, g). Twice more GFP+ cells were Blbp+ which implies gliogenic proliferation rather than neurogenic, IPC production in the absence of Cxcr4 expression in the mutant (fig. 4f, h). To rule out that the loss of IPCs was due to increased selective cell death of IPCs without Cxcr4, we examined cell death in these mice using staining for activated caspase-3 and found no increase (online suppl. fig. 3). Thus, Cxcr4 is required in the dentate lineage for efficient production of IPCs in the postnatal dentate.
Recent studies have shown that neurogenesis in the dentate is quite plastic, allowing environmental inputs to modulate the cellular composition of the dentate. Environmental influences such as stress, psychiatric disease, cognitive enrichment and exercise all somehow interact with the variety of signaling pathways that control maintenance and neurogenesis in dentate neural stem cells to shape the pool of new neurons in the dentate . We found a quite enhanced rate of neurogenesis at P15 compared to adult stages, which allowed us to use the Gli1-CreERt2 mice to cell autonomously manipulate target alleles in a small cohort of DG stem cells after a single TM injection. Conditional labeling of DG stem cells with a single TM injection allowed more refined manipulation of stem cells in the SGZ than in previous studies using other Cre lines that also have varying degrees of activity in rapidly dividing precursors in the dentate [31,32,33]. That the short-term labeled Gli-CreERt2 cells (using a YFP reporter, stained with GFP antibodies) also expressed Lef1 suggested that these cells are poised to respond to Wnt available in the SGZ niche. Since these cells are also identified by their strong Shh responsiveness (because of their Gli1 expression), we thought this was an interesting opportunity to test the consequences of manipulating signaling through these pathways - Wnt and Shh - in a well-defined cohort of stem cells.
Using conditional alleles that allow activation of Shh and Wnt signaling, we found that activation of either signaling pathway in receiving cells in a tonic manner has a strong effect to increase the overall rate of neuron production in the dentate. Importantly, recent studies have clearly shown that Wnt signaling is not physiologically ever likely to be seen as a tonic phenomenon, but is rather biphasic in the dentate . It would be valuable in future studies to identify methods allowing the biphasic activation of Wnt signaling in a more physiologic manner, as this would also likely avoid the problems with dendritic maturation and neuronal loss which we have seen in our study. However, what was quite clear is that activation of Wnt signaling in a tonic manner leads to a distinct pattern of neurogenesis compared to controls or activation of Shh signaling. Tonic Wnt signaling drives neurogenesis through an intermediate stage by increasing the pool of transient amplifying neurogenic precursors. The implication of this result is that the presence of both types of morphogenic ligands available to the dentate niche - Shh and Wnt - are necessary to help shape the type of neurogenic output seen from the dentate. This is quite intriguing in light of the recent work published by Dranovsky and colleagues  showing that neurogenesis in the dentate normally proceeds using a mixture of neurogenic modes, either including transient amplifying precursors or lacking them. Furthermore, they showed that environmental enrichment or stress led to changes in the relative balance of these two types of neurogenic output. This finding potentially links our results showing a disparity in the effects of Shh versus Wnt signaling activation to these different physiologic influences that shape the cellular makeup of the dentate.
It seems that activation of Wnt signaling in the expanding DG may have been the critical signaling development needed to meet the requirement to produce many neurons via a more rapid mode through the expansion of transient amplifying progenitors, while Shh signaling supports a baseline level of direct neurogenesis. It is interesting to consider the potential consequences of these different signaling pathways for the maintenance of long-lived neural stem cells in the dentate. Recent studies from two labs using different methodologies have revealed that the dentate may be composed of several distinct types of neural stem cells - some competent to undergo long-term continued production of neurons over time via asymmetric divisions  versus others that seem to exhaust themselves in the production of new neurons . The relationship between these different types of neurogenic divisions remains somewhat unclear and it is possible that technical differences in the approaches used to perform these studies  might be responsible for some of the differences. However, it is also possible that the different methods used in these studies led to distinct pools of neural stem cells being studied, and perhaps future studies may reveal that priming of neurogenesis by Shh versus Wnt may have distinct consequences for the long-term persistence and quiescence of SGZ stem cells.
We found that Wnt activation in the RGC induces Cxcr4 gene expression in the dentate lineage and that Cxcr4 is a direct target of Lef1. Presumably, Cxcr4 is then responsive to Cxcl12 produced by the dentate granule cells themselves [25,29,37]. Our study also shows that conditional deletion of Cxcr4 in the postnatal dentate using the Gli1-CreERt2 driver line compromises the ability of dentate stem cells to generate the normal numbers of Tbr2+ transient amplifying precursors and that constitutively active Cxcr4 induces the production of IPCs from embryonic RG progenitors. This provides at least one insight into the mechanism whereby Wnt activation leads to the increased production of transient amplifying cells during neurogenesis. The fact that Cxcr4 is not absolutely required to allow dentate neurogenesis explains why previous studies failed to show a major neurogenic phenotype in the postanatal dentate other than the defects in organization seen in the embryonic dentate [20,29,38]. We believe that the roles of Cxcl12-Cxcr4 signaling in the migration and organization of the dentate prenatally are important. But, to the extent that some cells are still able to reach the dentate, postnatal neurogenesis is able to be established and continues because of the multiple modes of neurogenesis that are possible in the dentate. However, we predict that conditional Cxcr4 mutant mice would respond abnormally to a variety of stimuli that are known to change the mode of dentate neurogenesis - e.g., environmental enrichment and stress .
Our studies revealing the roles of Shh and Wnt signaling in regulating two different modes of DG stem cell proliferation as well as the role of Cxcl12 signaling downstream of Wnt signaling may be important for understanding the role of these pathways in conditions such as depression and schizophrenia where alterations in neurogenesis in the dentate have been seen. Chronic stress represses Wnt signaling of the DG through expression of a Wnt inhibitor, Dickkopf-1, in the DG . Based on our studies we would predict that this would compromise the ability of the dentate to continue transient precursor-mediated neurogenesis. Interestingly, we also now know that mutations in genes associated with schizophrenia and mental retardation can have important consequences for Wnt signaling [40,41]. There are also some indications that changes in Wnt signaling in the dentate may be associated with declines in dentate neurogenesis associated with neurodegenerative diseases  and that restoring Wnt signaling might ameliorate these effects in experimental models [43,44,45]. Thus, we propose a model that a baseline ongoing mode of neurogenesis in the dentate is mostly dependent on continued Shh signaling but that the addition of Wnt activation drives the expansion of the pool of neurogenic precursors by supporting neurogenesis via transient amplifying precursors. This new framework may provide important clues for the expected roles of Shh and Wnt agonists in allowing the restoration or augmentation of dentate neurogenesis in a variety of disease states.
We thank Trung Huynh for technical assistance and Kurt Thorn and the Nikon Imaging Center at UCSF for use of the confocal microscope. This work was supported by R01 MH077694. S.J.P. is also supported by funds from the family of Glenn W. Johnson, Jr. The authors would also like to thank Dr. Alexandra Joyner for the use of the Gli1-CreERT2 mouse line.
Samuel J. Pleasure
675 Nelson Rising Lane
Room 214, UCSF
San Francisco, CA 94158 (USA)
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.